Vitale, E.; Rizzo, A.; Maistrello, L.; Guven, D.C.; Cauli, O.; Galetta, D.; Longo, V.
Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-Analysis. Cancers 2025, 17, 1571.
https://doi.org/10.3390/cancers17091571
AMA Style
Vitale E, Rizzo A, Maistrello L, Guven DC, Cauli O, Galetta D, Longo V.
Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-Analysis. Cancers. 2025; 17(9):1571.
https://doi.org/10.3390/cancers17091571
Chicago/Turabian Style
Vitale, Elsa, Alessandro Rizzo, Lorenza Maistrello, Deniz Can Guven, Omar Cauli, Domenico Galetta, and Vito Longo.
2025. "Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-Analysis" Cancers 17, no. 9: 1571.
https://doi.org/10.3390/cancers17091571
APA Style
Vitale, E., Rizzo, A., Maistrello, L., Guven, D. C., Cauli, O., Galetta, D., & Longo, V.
(2025). Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-Analysis. Cancers, 17(9), 1571.
https://doi.org/10.3390/cancers17091571
